Nutrigenomics: The Genome–Food Interface by Mead, M. Nathaniel
Environews FocusEnvironmental Health Perspectives • VOLUME 115 | NUMBER 12 | December 2007 A 583
Focus | Nutrigenomics
Nutrigenomics
TheGenome–Food Interface
E
fforts to unveil the etiology of human disease often recapitulate the nature
versus nurture debate. But today’s biologists concede that neither nature
nor nurture alone can explain the molecular processes that ultimately gov-
ern human health. The presence of a particular gene or mutation in most cases
merely connotes a predisposition to a particular disease process. Whether that
genetic potential will eventually manifest as a disease depends on a complex inter-
play between the human genome and environmental and behavioral factors. This
understanding has helped spawn numerous multidisciplinary gene-based approach-
es to the study of health and disease.
One such endeavor is nutrigenomics, the integration of genomic science with
nutrition and, when possible, other lifestyle variables such as cigarette smoking and
alcohol consumption. Although genes are critical for determining function, nutrition
modifies the extent to which different genes are expressed and thereby modulates
whether individuals attain the potential established by their genetic background.
Nutrigenomics therefore initially referred to the study of the effects of nutri-
ents on the expression of an individual’s genetic makeup. More recently, this defi-
nition has been broadened to encompass nutritional factors that protect the
genome from damage. Ultimately, nutrigenomics is concerned with the impact of
dietary components on the genome, the proteome (the sum total of all proteins),
and the metabolome (the sum of all metabolites). As in pharmacogenomics, where
a drug will have diverse impacts on different segments of the population,
researchers recognize that only a portion of the population will respond positively
to specific nutritional interventions, while others will be unresponsive, and still
other could even be adversely affected.
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A Focus on Polymorphisms
Numerous studies in humans, animals, and
cell cultures have demonstrated that
macronutrients (e.g., fatty acids and pro-
teins), micronutrients (e.g., vitamins), and
naturally occurring bioreactive chemicals
(e.g., phytochemicals such as flavonoids,
carotenoids, coumarins, and phytosterols;
and zoochemicals such as eicosapentaenoic
acid and docosahexaenoic acid) regulate
gene expression in diverse ways. Many of the
micronutrients and bioreactive chemicals in
foods are directly involved in metabolic
reactions that determine everything from
hormonal balances and immune compe-
tence to detoxification processes and the uti-
lization of macronutrients for fuel and
growth. Some of the biochemicals in foods
(e.g., genistein and resveratrol) are ligands
for transcription factors and thus directly
alter gene expression. Others (e.g., choline)
alter signal transduction pathways and chro-
matin structure, thus indirectly affecting
gene expression.
Much of the nutrigenomic focus has
been on single-nucleotide polymorphisms
(SNPs), DNA sequence variations that
account for 90% of all human genetic
variation. SNPs that alter the function of
“housekeeping genes” involved in the basic
maintenance of the cell are assumed to alter
the risk of developing a disease. Dietary fac-
tors may differentially alter the effect of one or
more SNPs to increase or decrease disease risk.
An elegant example of a diet–SNP inter-
action involves the common C677T poly-
morphism of the methylenetetrahydrofolate
reductase (MTHFR) gene. This variant caus-
es MTHFR enzyme activity to slow down.
This results in reduced capacity to use folate
(or folic acid) to convert homocysteine to
methionine and thence to the S-adenosyl-
methionine required for the maintenance
methylation of cytosine in DNA and con-
trol of gene expression, among many other
reactions. But the same variant also may
increase the form of folate that can be used
to make thymidine, one of the bases in
DNA, and to prevent mutagenic uracil from
being incorporated instead. This shift in
methylation status may explain why in a
low-folate environment (for example, where
there is low intake of folate-rich vegetables
such as spinach and asparagus or a lack of
supplemental folate) homozygous carriers of
the C677T polymorphism may be more
prone to developmental defects but at the
same time could be protected against certain
cancers.
The key point here is that the activity of
the reaction catalyzed by the MTHFR gene
can be modified depending on the amount of
two essential nutrients: folate, which is the
substrate for MTHFR, and riboflavin, a
cofactor of MTHFR. “Therefore, the risks
associated with MTHFR activity can be
markedly modified, for better or for worse,
depending on fortification and supplementa-
tion strategies,” says Michael Fenech, a
research scientist at the CSIRO Genome
Health and Nutrigenomics Laboratory in
Adelaide, Australia. “For example, in those
countries where mothers are required to sup-
plement with high-dose folic acid to prevent
neural tube defects in the infant, this practice
may actually allow more babies to be born
with the MTHFR C677T [polymorphism].”
These children would be less able to convert
folate to a usable form. On the other hand, if
the dietary environment in which these indi-
viduals have to grow is low in folate and
riboflavin, then they may struggle to survive
in good health. 
The field of nutrigenomics could not
have been launched without the recent devel-
opment of high-throughput -omic (genomic,
transcriptomic, proteomic, and metabolom-
ic) technologies. “These technologies enable
us to identify and measure many molecules
of each type at one time,” says Jim Kaput,
director of the newly established Division of
Personalized Nutrition and Medicine at the
FDA National Center for Toxicological
Research. “In the realm of genomics, for
example, we can now measure many varia-
tions in DNA, including tens of thousands of
single-nucleotide polymorphisms and copy
number variants, as well as many RNA mole-
cules. This is crucial, since most cases of
chronic diseases are not caused by mutations
in single genes but rather by complex interac-
tions among variants of several . . . genes.” 
These technologies currently enable iden-
tification of up to 500,000 SNPs per individ-
ual. Whereas nucleic acids can be analyzed
with either sequencing or hybridization tech-
nologies, protein and metabolites may
require slightly different techniques and
equipment depending upon the type of pro-
tein and chemical nature of the metabolite.
Nevertheless, Kaput says, the end result using
various -omic technologies is an incredibly
detailed window into the molecular makeup
of each individual.
Meanwhile, nutritional biochemists have
been busily cataloguing factors in food,
including dozens of essential nutrients and
tens of thousands of bioactive substances,
that can be correlated with molecular pat-
terns identified through the various -omic
technologies. The intersection of the genom-
ic and nutritional domains will require
sophisticated analytic techniques and, in
Kaput’s opinion, the open sharing of scientif-
ic research findings worldwide because of the
value derived from studying genomic and
nutritional patterns in different populations
and ethnic groups.
The Sweet Spot for Genomic Health
Not only the expression of genes but also
the physical integrity and stability of the
genome—what has been referred to as
“genome health”—is to a large degree deter-
mined by a steady supply of specific nutri-
ents. “There is increasing evidence that
genome instability, in the absence of overt
exposure to genotoxicants, is itself a sensitive
marker of nutritional deficiency,” says
Fenech. 
Fenech originated the concept of
“genome health nutrigenomics,” the science
of how nutritional deficiency or excess can
cause genome mutations at the base
sequence or chromosomal level. “The main
goal of this particular research discipline is
to define the optimal dietary intake and tis-
sue culture medium concentration to main-
tain damage to the genome at its lowest
possible level in vivo and in vitro, respective-
ly,” says Fenech. “This is critically important
because increased damage to the genome is
among the fundamental causes of infertility,
developmental defects, cancer, and neu-
rodegenerative diseases.” By the same token,
the selective use of genome-protective nutri-
ents in individuals with specific gene vari-
ants could potentially result in improved
resistance toward these major diseases.
Fenech believes we need to start viewing
foods and diets in terms of their content of
genome-protective nutrients.
Folate is among the nutrients most often
cited as critical to genomic stability.
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Controlled intervention study data published
in the July 1998 issue of Carcinogenesis and
the April 2001 issue of Mutation Research
indicate that a folate intake greater than
200 µg/day is required for chromosomal sta-
bility. Fenech’s team has shown that reduc-
ing plasma folate concentration from 120
to 12 nmol/L in vitro, which is considered to
be within the equivalent adequate range in
vivo, causes as much genome damage as that
induced by an acute exposure to 0.2 Gy of
ionizing radiation. “We concluded that even
moderate folate deficiency within the physio-
logical range causes as much DNA damage in
cultured lymphocytes as ten times the annual
allowed limit of exposure to X rays and other
forms of low linear energy transfer ionizing
radiation for the general population,” says
Fenech. He points out that the typical plas-
ma folate concentration for most populations
is only 10–30 nmol/L, a level adequate to
prevent anemia “but apparently insufficient
to minimize chromosomal damage.”
In the May 2005 issue of Carcinogenesis
Fenech and his colleagues identified nine key
nutrients that may affect genomic integrity in
various ways. When consumed in increasing
amounts in food, six of these nutrients
(folate, vitamin B12, niacin, vitamin E,
retinol, and calcium) are associated with a
reduction in DNA damage, whereas three
others (riboflavin, pantothenic acid, and
biotin) are associated with an increase in
DNA damage to the same extent observed
with occupational exposure to genotoxic and
carcinogenic chemicals. “These observations
indicate that nutritional deficiency or excess
can cause DNA damage on its own and that
the effects are of the same magnitude as that
of many common environmental toxicants,”
Fenech says. 
Paul Soloway, a nutrition professor at
Cornell University, points out that charac-
terizing diets or specific nutrients as being
genome-damaging or genome-protecting on
the basis of in vitro studies overlooks the
variations in benefits that exist over a life-
time, particular relative to the timing of dis-
ease onset. Moreover, nutritionists have long
understood that the optimal requirements
for many nutrients fall within a range
between deficiency and toxicity. In an envi-
ronment of vitamin fortification and supple-
mentation, Fenech’s findings may compel
health officials to be more vigilant about not
exceeding levels that could be harmful to the
genome or that might even promote the
growth of latent cancers. As an example of
how controversial these concerns may be,
some studies have reported protective bene-
fits from folate for initiation of colorectal
cancer, whereas others have found that this
nutrient may promote the growth of this
cancer once it is established.
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Research presented at a November 2007 meeting suggests that inosi-
tol (a member of the B vitamin family found in grains, seeds, nuts, brewer’s
yeast, and many other foods) and its derivative inositol hexaphosphate (IP6) help
protect against genetic damage from UVB and other radiation. In one experi-
ment, human skin cells treated with IP6 were less likely than untreated cells to
undergo apoptosis, indicating that they had less irreparable DNA damage. In
another experiment, mice genetically engineered for a propensity to skin cancer
drank water containing 2% IP6. Tumors developed in 23% of these mice com-
pared with 51% of mice that did not receive IP6. Use of a cream containing inosi-
tol and IP6 also protected against tumor development in mice exposed to UVB
radiation. The researchers suggest that people who are regularly exposed to ion-
izing radiation, such as airline pilots, frequent fliers, or people who handle
radioactive materials, might take IP6 prophylactically to prevent possible long-
term effects of exposure.
Source: Shamsuddin AM. Paper presented at: American Association for Cancer Research
Centennial Conference on Translational Cancer Medicine: From Technology to
Treatment; Singapore; 4–8 November 2007.Defining the optimal concentration of
micronutrients required to maintain cells in a
genomically stable state remains one of the
main challenges for nutrigenomics
researchers. This challenge becomes magni-
fied in the context of requirements for
diverse genetic backgrounds. Fenech cites the
example of individuals who show inherited
defects in DNA repair: these individuals may
be more vulnerable to the DNA-damaging
effects of moderate folate deficiency than
those who do not have such defects. 
There are thousands of DNA alterations
in each human cell daily; if not efficiently
repaired, our genome would rapidly be
destroyed. Diet and lifestyle are major medi-
ating factors in this equation. For example,
DNA damage is accelerated by oxidative
stressors such as tobacco smoke, strenuous
exercise, and a high-fat diet, according to a
study in the September 2002 issue of
Carcinogenesis. On the flip side, diets low in
fat and/or high in cruciferous vegetables have
been shown to lower the oxidative DNA
damage rate in humans, as indicated by
reduced urinary excretion of 8-oxo-7,8-
dihydro-2'-deoxyguanosine (8-oxodG). In
other reports, the dietary intake of vitamin C
determined the concentration of 8-oxodG in
human sperm DNA, while dietary fish oil
and calcium reduced oxidative DNA damage
rate in colonic epithelial cells.
When it comes to maintaining genomic
integrity, epigenetic changes such as those
involving DNA and histone modifications
are as profound as the genetic ones. “The
loss of normal epigenetic states can lead to
genomic rearrangements and increased fail-
ure of mismatch repair,” says Soloway. The
example of folate and MTHFR helps high-
light the dynamic interplay between the
genome and epigenome, he says: “Because
there are considerable epigenetic influences
of nutrients such as folate, one of the ways
by which alleles of MTHFR might control
nutrient-related phenotypes is through epi-
genetic mechanisms.” Changes in the
epigenome in response to dietary factors
may often precede changes in the genome,
and yet those genomic changes help solidify
the emergence of new epigenetic patterns
within the organism.
In addition to folate, various antioxidant
nutrients and phytochemicals are known to
enhance DNA repair and reduce oxidative
DNA damage, and such dietary contribu-
tions could theoretically compensate for
inherited defects in repair mechanisms. Also,
individuals with inherited polymorphisms
that lower the activity of antioxidant enzyme
systems such as manganese superoxide dis-
mutase and glutathione peroxidase may have
a higher requirement for dietary antioxidants
to prevent DNA damage or cancer risk. 
Focus | Nutrigenomics
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An article published in the October 2007 issue of the British Journal
of Nutrition warns that fortifying flour with folic acid—a move intended to pre-
vent neural tube defects among mothers who eat the flour—may lead to
numerous unforeseen health problems. Unlike the natural folates found in
leafy green vegetables, which are digested in the gut, synthetic supplements
are now believed to be metabolized in the liver. The study authors hypothesize
that the liver becomes saturated, and unmetabolized folic acid enters the blood
stream, where it can contribute to leukemia, arthritis, colorectal cancer, and
ectopic and multiple pregnancies. Other recent findings on a potential link
between supplementation and colorectal cancer are examined in two commen-
taries in the November 2007 issue of Nutrition Reviews. The new data follow on
the heels of the U.K. Food Standard Agency’s May 2007 approval of the addi-
tion of folic acid to flour. The United States, Canada, and Chile also currently
fortify flour with folic acid, and the policy is being considered for implementa-
tion in Australia, New Zealand, and Ireland.
Sources: Wright AJA, et al. 2007. Folic acid metabolism in human subjects revisited:
potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr
98(4):667–675; Kim Y-I. 2007. Folic acid fortification and supplementation—good for
some but not so good for others. Nutr Rev 65:504–511; Solomons NW. 2007. Food forti-
fication with folic acid: has the other shoe dropped? Nutr Rev 65:512–515.
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Although it is tempting to focus on
single-nutrient effects such as the folate
example mentioned above, nutrigenomics
researchers contend that the real focus
should be on the impact of multiple nutri-
tional imbalances (both excess and deficien-
cy) on the genome. In their May 2005
Carcinogenesis article, which described a
study of 190 healthy men and women with
an average age of 48 years, Fenech and his
colleagues showed that high intakes of vari-
ous B vitamins—riboflavin, pantothenic
acid, and biotin—actually increased
micronucleus frequency in lymphocytes, a
standard measure of genome damage. 
Going further, they studied the com-
bined effects of calcium or riboflavin with
different levels of folate intake, since earlier
studies had indicated that these dietary fac-
tors tend to interact in modifying the risk of
cancer, osteoporosis, and hip fractures.
Increasing one’s calcium intake further
enhanced the genome-protective effect of a
high-folate diet whereas a high riboflavin
intake further exacerbated genome damage
associated with a low-folate diet. This is con-
sistent with epidemiologic studies showing
that cancer rates tend to be higher among
populations that consume more red meat
(which is very high in riboflavin), more alco-
hol (which depletes folate), and fewer vegeta-
bles (a rich source of folate).
The promise of nutrition-modulated
DNA repair strategies has attracted the atten-
tion of cancer researchers in particular.
“Dietary factors can act to stabilize the
genome once genetic abnormalities have
occurred,” says gastroenterologist Graeme
Young, who directs the Flinders Centre for
Innovation in Cancer in Adelaide, Australia.
“The traditional diet–genome approach has
related protection to dietary lifestyle and
germline genotype,” he says. “Here we are
discussing dietary interaction with the abnor-
mal genome in potentially precancerous
cells.” Young and his colleagues are now
planning to explore the capacity of dietary
factors to regulate DNA repair mechanisms.
Nutrigenomic Links to Chronic
Disease 
Ben van Ommen, director of the European
Nutrigenomics Organization, and colleagues
hypothesize that all diseases can be reduced
to imbalances in four overarching processes:
inflammatory, metabolic, oxidative, and psy-
chological stress. Diseases arise because of
genetic predispositions to one or more of
these stressors. Nutrigenomics represents a
major effort to improve our understanding of
the role of nutrition and genomic interac-
tions in at least the first three of these areas,
says Kaput. In time, he adds, we will see
important contributions from nutrigenomics
for the prevention of many common modern
maladies, including obesity, diabetes, cardio-
vascular disease, cancer, inflammatory disor-
ders, age-related cognitive disorders, visual
function, and of course many vitamin defi-
ciency problems. 
Diabetes, obesity, and cardiovascular dis-
eases have been referred to by medical
anthropologists and others as “diseases of civi-
lization.” The reason is simple: when aborigi-
nal populations begin to adopt a high-sugar,
high-fat “Western diet” for the first time,
obesity and diabetes suddenly begin to appear
in those populations and typically increase at
rates commensurate with the adoption of the
new diet. Such observations have been dra-
matically borne out in studies of the Pima
Indians of Arizona and the indigenous people
of Hawaii. In both instances, the abandon-
ment of the traditional plant-rich, high-fiber
diet was followed by skyrocketing rates of
diabetes, obesity, and later cancer.
Over the course of human evolution, diet
has profoundly molded human metabolic
capacities and thus paved the way for the
emergence of modern diseases. From an evo-
lutionary perspective, diet is a limiting factor
that imposes selective pressures on a popula-
tion, much like other environmental factors.
Some genotypes within a population are
associated with higher nutrient needs, and
when those needs are not met, there will be
selection against those particular genotypes.
However, when those needs are met—for
example, the need for extra calories from car-
bohydrates and dietary fat—the gene that
confers the high nutrient requirement will
then persist in the population. This could
well be the case for genes linked with obesity
and diabetes.
Soloway notes that in cases where cer-
tain gene alleles confer some selective advan-
tage, high levels of the required nutrient can
actually lead to an expanded frequency of
those alleles in a population. “In such cases,
nutrient availability can provide a selective
pressure that drives genotypic shifts in a
population,” he says. 
From the nutrigenomic perspective, dia-
betes and obesity are both the result of an
imbalanced diet interacting with genes that
were once functional and adaptive in an earli-
er phase of human evolution, when food was
less abundant. In the modern context, these
same genes are considered to code for hor-
monal or metabolic tendencies that have
become maladaptive and pathological in the
modern environment. Risk of developing
these diseases is thought to be modulated by
genetic susceptibility differences among
ancestral groups to the effect of the Western
diet in precipitating insulin resistance. 
In addition, says Lynn Ferguson, a nutri-
tion professor at the University of Auckland
in New Zealand and program leader of the
New Zealand National Centre for Research
Excellence in Nutrigenomics, “the control of
food intake is profoundly influenced by gene
variants encoding taste receptors or those
encoding a number of peripheral signaling
peptides such as insulin, leptin, ghrelin,
cholecystokinin, and corresponding recep-
tors. Total dietary intake, and the satiety
value of various foods, will profoundly modi-
fy the impact of these genes.” In volume 10,
number 2 (2006) of Molecular Diagnosis &
Therapy, Ferguson cites studies that have
linked five common SNPs with increased
obesity risk and resistance to weight reduc-
tion. “These SNPs represent promising tar-
gets for future nutrigenomic studies of people
at risk for obesity,” she says. Taken together,
these findings provide a strong scientific
rationale for avoiding a generic, one-size-fits-
all approach to the problem of obesity.
Given that obesity is itself a risk factor for
diabetes, cardiovascular disease, and various
cancers, it is worthwhile to focus on the
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ietary factors can act to stabilize the genome once
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diet–genome approach has related protection to
dietary lifestyle and germline genotype.Here we are dis-
cussing dietary interaction with the abnormal genome in
potentially precancerous cells.
–Graeme Young
Flinders Centre for Innovation in Cancernutrigenomic aspects of this disease. A study
conducted at the University of Navarra in
Pamplona, Spain, and published in the
August 2003 issue of the Journal of Nutrition
showed that women with a Glu27 variant
and a carbohydrate intake constituting more
than 49% of total caloric consumption had a
nearly three-fold increase in their risk of
developing obesity. Importantly, an alterna-
tive variant of that same gene was not linked
with a greater obesity risk in relation to the
same carbohydrate–calorie intake levels. This
could help explain why some women on
high-carbohydrate diets gain weight while
others do not.
Abdominal obesity, independent of gen-
eralized adiposity, predicts insulin resistance,
type 2 diabetes, dyslipidemia, and cardiovas-
cular disease. Endocrinologist Jerry Green-
field and colleagues at St. Vincent’s Hospital
in Sydney, Australia, recently reported that
high polyunsaturated fat intake was associat-
ed with lower levels of abdominal fat in
women at low genetic risk for abdominal
obesity but not in women at high genetic
risk. Also, a moderately high alcohol intake
(1–1.5 drinks per day) was associated with
approximately 20% less abdominal fat than
lower intakes, but only in women genetically
predisposed to abdominal obesity. This
study, published in the November 2003
Journal of Clinical Endocrinology and Metab-
olism, indicates that various gene–diet inter-
actions could be a key part of the abdominal
obesity equation.
The APOE gene offers another example
of how certain polymorphisms may
predispose their bearers to chronic diseases.
Each of three phenotypes carries a different
probability of cardiovascular disease risk
and responds differently to lifestyle and
environmental factors, including dietary
variables such as the amount and type of
dietary fat. Most people in the United
States have the APOE3 phenotype and
respond favorably to a lower intake of
dietary fat and regular exercise: their cho-
lesterol levels drop and overall cardiovascu-
lar health improves. However, about 20%
of the U.S. population carries at least one
variant denoted as APOE-ε4, a polymor-
phism associated with elevated total choles-
terol level, as well as an increased risk of
both type 2 diabetes and Alzheimer disease.
The SNP also abrogates the protective
effects seen with moderate alcohol con-
sumption and greatly increases the cardio-
vascular risks associated with smoking,
dramatically boosting the risk of heart
attack in such individuals.
“The implication here is that anyone
with this genotype should be rigorously
attentive to their diet and lifestyle,” says
Ferguson. “These individuals should avoid
smoking and alcohol while undertaking
exercise and eating a diet low in saturated
fat. Nonetheless, at present, very few peo-
ple are aware of their APOE genotype.”
Lack of the awareness of such SNP–
diet–lifestyle interactions is not only a
drawback for public health education, but
also may result in null findings in epidemi-
ologic studies when in fact certain seg-
ments of the study population are highly
vulnerable to diseases that are linked with a
given SNP. 
Future Research Directives and
Challenges
Identifying the SNP–diet and SNP–nutrient
interactions that cause chronic disease is
challenging because of the complexities
inherent in studying genotypes and in assess-
ing dietary and nutrient intakes. At this
time, few if any of the SNP–diet associations
that have been reported in epidemiologic
studies have been replicated, and many have
been plagued by a lack of appropriate statis-
tical power and other methodologic prob-
lems. Ultimately, because many cases of
chronic diseases are influenced by different
diets, nutrition–genome interactions will not
be found unless diet and genotype are con-
trolled and changed in the experimental
design (same diet with different genotypes,
and different genotypes with the same diet). 
“Diet–gene interactions are highly com-
plex and hard to predict, thus demonstrating
the need for highly controlled genotypes and
environmental conditions that allow for
identifying different regulatory patterns
based on diet and genotype,” Kaput says.
“The challenges we now face may ultimately
require a nutrigenomics project on the scale
of the Human Genome Project in order to
identify genes that cause or promote chronic
disease and the nutrients that regulate or
influence the activity of these genes.” 
Because human intervention studies are
costly and difficult to conduct, observational
studies (which detect associations, not causal
relationships) will likely continue to domi-
nate the epidemiologic approach to nutri-
genomics. For interventional and mechanistic
data, in vivo animal studies will be heavily
favored because lab animals can be selected
for minimal genetic variation and shorter life
spans. Moreover, it is much easier to control
and monitor the dietary intakes of animals
than those of humans.
Kaput notes that assessments of dietary
intake, albeit mundane to the outside world,
may represent one of the biggest impedi-
ments to the success of large-scale human
nutrigenomic studies. “Quantifying food
intake is challenging because free-living
humans simply do not regard daily life as a
science experiment where the amount and
type of food is accurately recorded,” he says.
To avoid measurement problems such as
misclassification, more reliable measurement
tools for assessing nutrient intake will be
needed in the years ahead. 
Proponents of nutrigenomics research
have cited the population-wide prevention
and treatment of vitamin deficiency as a top
public health priority. Since vitamin deficien-
cies are highly prevalent in socioeconomically
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iet–gene interactions are highly complex and hard
to predict,thus demonstrating the need for highly
controlled genotypes and environmental conditions
that allow for identifying different regulatory patterns
based on diet and genotype.The challenges we now face
may ultimately require a nutrigenomics project on the scale
of the Human Genome Project in order to identify genes
that cause or promote chronic disease and the nutrients
that regulate or influence the activity of these genes.
–Jim Kaput
FDA National Center for Toxicological Researchchallenged populations around the world,
and because large sample sizes are needed to
test nutrigenomic relationships, Kaput and
his colleagues are pushing for an internation-
al effort to study micronutrient needs based
on differing genetic makeups among differ-
ent ancestral groups.
Bruce Ames, a molecular biologist at
Children’s Hospital Oakland Research
Institute in California, has documented a
number of polymorphisms in genes that
affect the binding of coenzymes, some of
which are essential vitamins. “With these
types of evidenced-based findings within the
nutrigenomic framework, I believe we’ll have
more ammunition to convince government
and public health officials to tackle the issue
of vitamin deficiency around the world,”
Kaput says. “With this more targeted
approach, we’re more likely to see political
and economic forces fall in place to solve the
problem. . . . Although the complexities are
substantial, I believe nutrigenomic approach-
es offer the best hope for understanding the
molecular processes that maintain health and
prevent disease.”
For Fenech, one of the key objectives of
nutrigenomics for society is to diagnose and
nutritionally prevent DNA damage on an
individual-by-individual basis. He has
devised the concept of the Genome Health
Clinic, a new mode of health care based on
the diagnosis and nutritional prevention of
DNA damage and the diseases that result
therefrom. In recent years, a number of
nutritional/metabolic/diagnostic testing com-
panies such as Genova and MetaMetrix have
started to sell genomic profiling tests to help
guide decision making around dietary sup-
plements. With the increasingly lower pric-
ings for analyzing SNPs in individuals, the
population-level potential for dietary opti-
mization based on nutrigenomic approaches
seems truly awesome. Even in the absence of
information on an individual’s genotype, it is
practical to use nutrition-sensitive genome
damage biomarkers, such as the micro-
nucleus assay, to determine whether dietary
and/or supplement choices are causing bene-
fit or harm to a person’s genome. 
Says Fenech, “In the near future, instead
of diagnosing and treating diseases caused by
genome or epigenome damage, health care
practitioners may be trained to diagnose and
nutritionally prevent or even reverse genomic
damage and aberrant gene expression.
Nutrigenomics will help usher in the devel-
opment of new functional foods and supple-
ments for genome health that can be mixed
and matched so that overall nutritional
intake is appropriately tailored to an individ-
ual’s genotype and genome status.”
M. Nathaniel Mead
Environmental Health Perspectives • VOLUME 115 | NUMBER 12 | December 2007 A 589
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Antioxidants are known for their ability to slow the oxidation that
damages cells. But the human body doesn’t derive the same level of benefit
from all antioxidants. Recently nutritionists with the USDA Agricultural Research
Service measured the plasma antioxidant capacity (AOC) of study subjects fol-
lowing a single meal of blueberries, cherries, dried plums, dried plum juice,
grapes, kiwis, or strawberries. They reported in the April 2007 Journal of the
American College of Nutrition that blueberries, grapes, and kiwifruit yielded the
greatest increases in plasma AOC. Plums—despite their high antioxidant con-
tent—did not raise plasma AOC levels, probably because chlorogenic acid, the
antioxidant in which they are richest, is not readily absorbed by humans.
Norwegian researchers showed in the August 2007 issue of the Journal of
Nutrition that anthocyanins from bilberries and black currants reduced levels of
transcription factor NF-κB in cultured cells. NF-κB orchestrates a wide range of
inflammatory responses. In humans, anthocyanin supplementation decreased
interleukin-8, IFN, and normal T cell expression by 25%, 25%, and 15%, respec-
tively, over placebo. The authors suggest that anthocyanins and/or their
metabolites may serve as redox buffers capable of suppressing oxidative stress
and thereby dampen the inflammatory response by direct reactive oxygen
species scavenging.
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